• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Fundamental study about the cancer-of-the-mouth stem cell andmolecular target drug under low oxygen environment

Research Project

Project/Area Number 23659950
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Surgical dentistry
Research InstitutionNagasaki University

Principal Investigator

NARUSE Tomofumi  長崎大学, 大学病院, 助教 (70549609)

Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Keywords臨床腫瘍学 / mTOR阻害薬 / リンパ節転移 / 癌幹細胞 / 低酸素 / 低酸素領域 / 分子標的治療薬
Research Abstract

By the result obtained until now, a mTOR inhibitory drug Proliferation potency control of oral squamous cell carcinoma, Also to the control of a gene which participates not only in ruining maintenance of a cancer stem cell function but in lymph node metastasis, it is effective and the possibility that the application to the cancer of the mouth of a mTOR inhibitory drug was useful as future new molecular target medical treatment was suggested.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (2 results)

All 2012

All Presentation (2 results)

  • [Presentation] 口腔扁平上皮癌におけるmTOR阻害薬everolimusの抗腫瘍効果について2012

    • Organizer
      日本口腔外科学会総会・学術集会
    • Place of Presentation
      横浜市
    • Related Report
      2012 Final Research Report
  • [Presentation] mTOR阻害薬everolimusの口腔扁平上皮癌細胞株に対する抗腫瘍効果について2012

    • Author(s)
      鳴瀬 智史
    • Organizer
      第57回日本口腔外科学会総会・学術集会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Related Report
      2012 Annual Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi